Ecofibre Limited Provides Update on Australian S3 CBD Research
September 06, 2021 at 09:03 pm EDT
Ecofibre Limited has previously announced that it received Human Research Ethics Committee approval to undertake a Phase IIb double blind, randomised, placebo-controlled, multi-site clinical trial for sleep disturbances. Enrolment in the study is progressing despite the impact of COVID-19 restrictions in Australia. A number of online screening surveys have been received and are being reviewed in accordance with study criteria, and the study's first participant has now been enrolled.